<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med Res</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med Res</journal-id><journal-id journal-id-type="publisher-id">Elmer Press</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine Research</journal-title></journal-title-group><issn pub-type="ppub">1918-3003</issn><issn pub-type="epub">1918-3011</issn><publisher><publisher-name>Elmer Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28392859</article-id><article-id pub-id-type="pmc">5380172</article-id><article-id pub-id-type="doi">10.14740/jocmr2763w</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Whole-Body Vibration Training During a Low Frequency Outpatient Exercise Training Program in Chronic Obstructive Pulmonary Disease Patients: A Randomized, Controlled Trial</article-title><alt-title alt-title-type="short">WBVT in COPD</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spielmanns</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="Aa">a</xref><xref ref-type="aff" rid="Ab">b</xref><xref ref-type="aff" rid="Ah">h</xref><xref ref-type="corresp" rid="CORi">i</xref></contrib><contrib contrib-type="author"><name><surname>Gloeckl</surname><given-names>Rainer</given-names></name><xref ref-type="aff" rid="Ac">c</xref><xref ref-type="aff" rid="Ad">d</xref><xref ref-type="aff" rid="Ah">h</xref></contrib><contrib contrib-type="author"><name><surname>Gropp</surname><given-names>Jana Marie</given-names></name><xref ref-type="aff" rid="Aa">a</xref></contrib><contrib contrib-type="author"><name><surname>Nell</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="Ae">e</xref></contrib><contrib contrib-type="author"><name><surname>Koczulla</surname><given-names>Andreas Rembert</given-names></name><xref ref-type="aff" rid="Ae">e</xref></contrib><contrib contrib-type="author"><name><surname>Boeselt</surname><given-names>Tobias</given-names></name><xref ref-type="aff" rid="Ae">e</xref></contrib><contrib contrib-type="author"><name><surname>Storre</surname><given-names>Jan Hendrik</given-names></name><xref ref-type="aff" rid="Af">f</xref><xref ref-type="aff" rid="Ag">g</xref></contrib><contrib contrib-type="author"><name><surname>Windisch</surname><given-names>Wolfram</given-names></name><xref ref-type="aff" rid="Ab">b</xref><xref ref-type="aff" rid="Af">f</xref></contrib></contrib-group><aff id="Aa"><label>a</label>Medical Clinic and Pulmonary Rehabilitation in Leverkusen (April), Remigius Hospital, Leverkusen, Opladen, Germany</aff><aff id="Ab"><label>b</label>Faculty of Health, Department of Pneumology, University of Witten/Herdecke, Germany</aff><aff id="Ac"><label>c</label>Department of Respiratory Medicine &#x00026; Pulmonary Rehabilitation, Schoen Klinik Berchtesgadener Land, Schoenau am, Koenigssee, Germany</aff><aff id="Ad"><label>d</label>Department of Prevention, Rehabilitation and Sports Medicine, Klinikum Rechts der Isar, Technische Universitat Munchen (TUM), Munic, Germany</aff><aff id="Ae"><label>e</label>Pulmonary Rehabilitation, Phillips University Marburg, Germany</aff><aff id="Af"><label>f</label>Department of Pneumology, Cologne Merheim Hospital, Kliniken der Stadt Koeln GmbH, Germany</aff><aff id="Ag"><label>g</label>Department of Pneumology, University Hospital, Freiburg, Germany</aff><aff id="Ah"><label>h</label>These authors contributed equally to this study.</aff><author-notes><corresp id="CORi"><label>i</label>Corresponding Author: Marc Spielmanns, Medical Clinic and Pulmonary Rehabilitation in Leverkusen (April), St. Remigius Krankenhaus, An St. Remigius 26 ; 51379 Leverkusen, Germany. Email: <email>spielmanns@k-plus.de</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>01</day><month>4</month><year>2017</year></pub-date><volume>9</volume><issue>5</issue><fpage>396</fpage><lpage>402</lpage><history><date date-type="accepted"><day>27</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>Copyright 2017, Spielmanns et al.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="a1"><title>Background</title><p>The aim of the study was to investigate whether whole-body vibration training (WBVT) can be applied beneficially within an outpatient low frequency exercise program.</p></sec><sec id="a2"><title>Methods</title><p>In a prospective, controlled, randomized study, WBVT effectiveness and safety were investigated in COPD stage II-IV patients undergoing a 3-month training program. Participants took part in a 90-min circuit training once a week. On top patients were randomized to either perform squats with WBVT, or without (conventional training group (CTG)). Before and after the intervention, a sit-to-stand test (STST), a 6-min walk test (6-MWT), the COPD assessment test (CAT), and the chronic respiratory disease questionnaire (CRQ) were evaluated.</p></sec><sec id="a3"><title>Results</title><p>Twenty-eight out of 55 patients completed the study (n = 12 WBTV, n = 16 CTG). The STST time remained nearly constant for the CTG (&#x00394; -0.8 &#x000b1; 3.1 s) and the WBVT (&#x00394; 1.4 &#x000b1; 3.2 s; P = 0.227), respectively. Similarly, for both WBVT and CTG, the 6-min walk distance remained unchanged (&#x00394; 7 &#x000b1; 55 m vs. 9 &#x000b1; 45 m, P = 0.961). In three out of four categories, the CRQ scores showed a significant improvement within WBVT, and in one category when comparing across groups. The CAT score dropped by -0.8 &#x000b1; 2.9 points within CTG and by 2.4 &#x000b1; 2.7 points within WBVT (P = 0.105). There were no adverse events related to WBVT.</p></sec><sec id="a4"><title>Conclusion</title><p>The implementation of WBVT in the context of an outpatient low frequency exercise program did not significantly improve the patients&#x02019; exercise capacity. An improvement in CAT and partially in CRQ was shown within WBVT. However, regarding the high dropout rate (49%), these results must be interpreted with caution.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>Whole-body vibration training</kwd><kwd>Pulmonary rehabilitation</kwd><kwd>COPD</kwd><kwd>Sit-to-stand test</kwd><kwd>6-min walk test</kwd><kwd>Exercise training</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>The clinical relevant benefits of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) are proven on a high level of evidence [<xref rid="R01" ref-type="bibr">1</xref>]. Furthermore, pulmonary rehabilitation following an exacerbation of COPD leads to a reduction of re-hospitalization [<xref rid="R02" ref-type="bibr">2</xref>] and mortality [<xref rid="R03" ref-type="bibr">3</xref>] and can positively influence the progression of COPD [<xref rid="R04" ref-type="bibr">4</xref>].</p><p>Physical training represents a major component of pulmonary rehabilitation programs [<xref rid="R05" ref-type="bibr">5</xref>, <xref rid="R06" ref-type="bibr">6</xref>]. While the Anglo-American hemisphere emphasizes exercise training only [<xref rid="R07" ref-type="bibr">7</xref>], a multidisciplinary approach of pulmonary rehabilitation is preferred in Germany [<xref rid="R08" ref-type="bibr">8</xref>]. Since benefits of rehabilitation usually diminish about 1 year after such programs, the question of sustainability is discussed on national and international levels. In Germany, outpatient post-rehabilitation programs are established amongst others, and its policies as well as content are regulated for this purpose [<xref rid="R09" ref-type="bibr">9</xref>]. The content of these follow-up programs (usually low frequency and low intensity) is well documented and thoroughly described elsewhere [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R11" ref-type="bibr">11</xref>].</p><p>The advantage of using whole-body vibration training (WBVT) in different rehabilitation programs like patients with osteoporosis or neurological illness has been investigated extensively [<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>]. The method has been also evaluated in a recent study during an inpatient rehabilitation program of patients with severe to very severe COPD. The study by Gloeckl et al showed a significantly larger increase in exercise capacity when patients trained with WBVT in addition to conventional endurance and strength training [<xref rid="R14" ref-type="bibr">14</xref>]. As a training device for WBVT, a side alternating vibration platform (Galileo<sup>&#x000ae;</sup>) was used. The concept of WBVT is based on imitating a human&#x02019;s natural walking motion sequence. The fast side alternating movement simulates the walking motion sequence with adjustable amplitude and frequency. As a natural mechanism to this kind of vibration, the body reacts by contracting muscles alternatively in the lower left and right extremities. Beyond a frequency threshold of 10 - 12 Hz, these muscle contractions are not voluntary anymore, but are induced by muscle stretch reflexes [<xref rid="R15" ref-type="bibr">15</xref>]. WBVT activates muscles from the legs up to the torso, increases the perfusion especially in the legs, and stimulates the overall blood circulation.</p><p>We hypothesized that a complementary WBVT could also be used as an effective training supplement in a low frequency and low intensity outpatient exercise program in COPD patients. The primary aim of this study was to investigate whether WBVT would lead to a significant increase in the five-repetition sit-to-stand test (STST) in comparison to a non-WBVT training group.</p></sec><sec sec-type="materials | methods" id="s2"><title>Methods</title><sec id="s2a"><title>Setting and study design</title><p>The study represents a prospective, randomized and controlled interventional study at the St. Remigius Hospital in Leverkusen, Germany. Patients participated in an outpatient exercise training program once a week. In total, 94 patients with COPD were screened for eligibility from November 2013 through September 2015. Following the examination of inclusion and exclusion criteria, a detailed explanation was given and patients signed informed consent. Randomization was performed according to a computer-generated randomization list provided by the study statistician using a 1:1 randomization without block randomization. The group allocation was performed by a third party not being involved in patient recruitment. Group allocation was done after patients have signed informed consent. The study flow chart is presented in <xref ref-type="fig" rid="F1">Figure 1</xref>. The ethics commission of the University of Witten-Herdecke has verified the study (No. 124/2013). Then, the study was registered in the German Clinical Trials Register (DRKS No. 00006070).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Study flow chart. WBVT: intervention group with whole-body vibration training; CTG: conventional training group. </p></caption><graphic xlink:href="jocmr-09-396-g001"/></fig></sec><sec id="s2b"><title>Inclusion criteria</title><p>Patients with COPD at stages II-IV according to GOLD guideline were included [<xref rid="R01" ref-type="bibr">1</xref>]. Patients had to be willing to complete the training entirely. Furthermore, they had to participate in pre- and post-assessments at the outpatient center. The participants had to give a written consent to the data acquisition and study participation.</p></sec><sec id="s2c"><title>Exclusion criteria</title><p>Exclusion criteria were acute COPD exacerbation within the last 28 days prior to study inclusion and presence of any contraindication for WBVT (e.g. artificial joint replacement, recent or planned surgery, a history of deep vein thrombosis or known aortic aneurysm).</p></sec><sec id="s2d"><title>Measurements</title><p>Initially, the inclusion and exclusion criteria were reviewed. In the beginning and the end of the training intervention, patients performed the following assessments: 6-min walk test (6-MWT), five-repetition STST, the 1-min STST, body plethysmography, COPD assessment test (CAT) and chronic respiratory disease questionnaire (CRQ).</p></sec><sec id="s2e"><title>Pulmonary function testing</title><p>Spirometry and body plethysmography (PowerCube, Fa.Ganshorn<sup>TM</sup>, Germany) were conducted in the beginning and the end of the study, while respecting the guidelines of the American Thoracic Society [<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R17" ref-type="bibr">17</xref>], and utilizing reference values of the European Respiratory Society (ERS) [<xref rid="R18" ref-type="bibr">18</xref>].</p></sec><sec id="s2f"><title>STST</title><p>STSTs were carried out with a chair of standard height (46 cm). To avoid support with the arms, patients were asked to cross them in front of the chest. Initially, the test was demonstrated by an experienced colleague and then performed by the participant. Two STST versions were used. Firstly, the participants were asked to conduct the motion in their own pace as often as possible within 1 min (1-min STST). Attention was given towards a full extension of lower extremities. The amount of fully completed repetitions was recorded as outcome parameter. Patients were allowed to use rest periods to complete the 1-min test, if necessary [<xref rid="R19" ref-type="bibr">19</xref>].</p><p>Following, after a 15-min break, the second STST version was performed. Here, the time the patient needed to complete five repetitions of getting up and sitting down as quick as possible, was measured (five-repetition STST).</p></sec><sec id="s2g"><title>6-MWT</title><p>Participants were asked to walk as far as possible on a 30-m track back and forth in their own pace (without running), adhering to the guidelines for the 6-MWT of the American Thoracic Society [<xref rid="R20" ref-type="bibr">20</xref>].</p></sec><sec id="s2h"><title>Health-related quality of life</title><sec id="s2h1"><title>CRQ</title><p>The health-related quality of life was assessed using the German version of the CRQ. The CRQ consists of four domains namely dyspnea, fatigue, emotional function and mastery. Evaluation of the individual domains reaches from 1 (major impairment) to 7 (without impairment) [<xref rid="R21" ref-type="bibr">21</xref>].</p></sec><sec id="s2h2"><title>CAT</title><p>The questionnaire, filled in by the patients themselves, evaluates the global impact of the COPD (e.g. cough, expectoration, dyspnea, and stenocardia) on the health status. Each of the eight questions is rated between 0 and 5 points resulting in a maximum score of 40 points. A score of 0 is the best possible result. Higher values indicate a serious negative impact of COPD on the participant&#x02019;s quality of life [<xref rid="R22" ref-type="bibr">22</xref>].</p></sec><sec id="s2h3"><title>Intervention</title><p>Within the outpatient pulmonary rehabilitation groups, participants were randomly assigned to a CTG or a WBVT group. In each training session, the WBVT group performed squat exercises on the side-alternating Galileo vibration platform (Novotec Medical, Pforzheim, Germany). Patients performed three sets of up to 20 squat repetitions with a frequency of 24 - 26 Hz and an amplitude of 3 mm. Training was conducted shoeless and in following sequence: slightly bended knees (10 - 20&#x000b0;), standing and bending of 30 - 40&#x000b0; without holding on with arms. The CTG conducted the same amount of squat exercises but without WBVT. The remaining content of the training stayed the same and had a duration of 90 min per unit. It included exercises with dumbbells and Thera-band<sup>&#x000ae;</sup>, different modalities of walking, ergometer training, stair climbing, dance, and more. It furthermore consisted of endurance training and rolling walker training orientating at activities of daily living. The full training content is described extensively elsewhere [<xref rid="R11" ref-type="bibr">11</xref>]. Over the course of 3 months, the described training was continued once a week. All adverse events occurring during or after the training, e.g. cardiac incidents or injuries, as were noted.</p></sec><sec id="s2h4"><title>Trial objectives</title><p>The primary objective was the change in measured time of the five-repetition STST in group comparison, while the secondary objectives were changes in 6-min walk distance (6MWD), 1-min STST, CAT, CRQ and adverse events recorded by the participants or the staff.</p></sec></sec><sec id="s2i"><title>Statistical analysis</title><p>A significance value of 5%, power of 80% in combination with an expected mean difference of 2.6 s and an estimated standard deviation (SD) of 2.9 s, result in a targeted case number of 20 patients per group.</p><p>The statistical analyses were conducted using the statistics program SPSS 20 (IBM, Inc., USA). For describing the patient population, the results are provided by mean values with SD. For a comparing analysis over time, the Wilcoxon-Mann-Whitney test (W-test) was applied. To compare the CTG and WBVT group, the difference of the measurement parameters between initial and final measurement was determined. These group differences were analyzed for statistical alterations with the Mann-Whitney U test (U-test). For categorical variables, the Fisher&#x02019;s exact test was applied. All tests were two-tailed, and adopted a significance level of P &#x0003c; 0.05.</p></sec></sec><sec id="s3"><title>Results</title><p>Twenty-eight out of 55 patients completed the study and were included in the analysis, 12 from WBVT and 16 from CTG, respectively. Almost half of the patients (49%) dropped out of the study and did not finish the 12-week period. Reasons for the dropouts are presented in <xref ref-type="fig" rid="F1">Figure 1</xref>. None of the groups&#x02019; baseline characteristics showed statistically significant differences, except a significant higher number of cardiovascular comorbidities in the WBVT group (<xref ref-type="table" rid="T1">Table 1</xref>). In <xref ref-type="table" rid="T2">Table 2</xref>, the initial values of both dropouts and those who completed are compared. The participants in WBVT with the highest initial impairments in exercise capacity (6-MWT and both versions of STST) and lung function (FEV1% pred.) proved to be more inclined not finishing the study.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Anthropometric Data, Baseline Characteristics</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WBVT (n = 12)</th><th align="left" rowspan="1" colspan="1">CTG (n = 16)</th><th align="left" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (M/F)</td><td align="left" valign="top" rowspan="1" colspan="1">8/4</td><td align="left" valign="top" rowspan="1" colspan="1">9/7</td><td align="left" valign="top" rowspan="1" colspan="1">0.705</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="top" rowspan="1" colspan="1">62.4 &#x000b1; 20.3</td><td align="left" valign="top" rowspan="1" colspan="1">68.0 &#x000b1; 9.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.767</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">COPD (II/III/IV)</td><td align="left" valign="top" rowspan="1" colspan="1">4/6/2</td><td align="left" valign="top" rowspan="1" colspan="1">7/7/2</td><td align="left" valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FEV1% pred.</td><td align="left" valign="top" rowspan="1" colspan="1">48.4 &#x000b1; 20.9</td><td align="left" valign="top" rowspan="1" colspan="1">51.2 &#x000b1; 17.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.642</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6-MWT, m</td><td align="left" valign="top" rowspan="1" colspan="1">553 &#x000b1; 67</td><td align="left" valign="top" rowspan="1" colspan="1">481 &#x000b1; 121</td><td align="left" valign="top" rowspan="1" colspan="1">0.077</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1-min STST, repetitions</td><td align="left" valign="top" rowspan="1" colspan="1">20.8 &#x000b1; 6.0</td><td align="left" valign="top" rowspan="1" colspan="1">16.8 &#x000b1; 6.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.131</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5-rep STST, s</td><td align="left" valign="top" rowspan="1" colspan="1">11.9 &#x000b1; 2.1</td><td align="left" valign="top" rowspan="1" colspan="1">13.9 &#x000b1; 4.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.642</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Arterial hypertension</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">0.227</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardiovascular diseases</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cancer</td><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">0.595</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes mellitus</td><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">0.172</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Other</td><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>COPD: chronic obstructive pulmonary disease; FEV1% pred.: forced expiratory volume in one second % of target; 6-MWT: walking distance in 6-min walk test; m: meter; 1-min STST: 1-min sit-to-stand test; 5-rep STST: sit-to-stand test with five repetitions; WBVT: intervention group with whole-body vibration training; CTG: conventional training group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Comparison Completers and Dropouts</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WBVT group completers (n = 12) (1)</th><th align="left" rowspan="1" colspan="1">WBVT dropouts (n = 16) (3)</th><th align="left" rowspan="1" colspan="1">(1) vs. (3)</th><th align="left" rowspan="1" colspan="1">CTG group completers (n = 16) (2)</th><th align="left" rowspan="1" colspan="1">CTG group dropouts (n = 11) (4)</th><th align="left" rowspan="1" colspan="1">(2) vs. (4)</th><th align="left" rowspan="1" colspan="1">K-test (1) vs. (2) vs. (3) vs. (4)</th><th align="left" rowspan="1" colspan="1">(3) + (4) = (5)</th><th align="left" rowspan="1" colspan="1">(1) vs. (5)</th><th align="left" rowspan="1" colspan="1">(2) vs. (5)</th><th align="left" rowspan="1" colspan="1">K-test (1) vs. (2) vs. (5)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">COPD (II/III/IV)</td><td align="left" valign="top" rowspan="1" colspan="1">6/2/04</td><td align="left" valign="top" rowspan="1" colspan="1">5/5/05</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">7/2/07</td><td align="left" valign="top" rowspan="1" colspan="1">4/5/0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FEV1 (%)</td><td align="left" valign="top" rowspan="1" colspan="1">48.4 &#x000b1; 20.9</td><td align="left" valign="top" rowspan="1" colspan="1">42.1 &#x000b1; 20.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.369</td><td align="left" valign="top" rowspan="1" colspan="1">51.2 &#x000b1; 17.3</td><td align="left" valign="top" rowspan="1" colspan="1">52.1 &#x000b1; 18.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.910</td><td align="left" valign="top" rowspan="1" colspan="1">0.482</td><td align="left" valign="top" rowspan="1" colspan="1">46.2 &#x000b1; 19.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.746</td><td align="left" valign="top" rowspan="1" colspan="1">0.341</td><td align="left" valign="top" rowspan="1" colspan="1">0.637</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6-MWT, m</td><td align="left" valign="top" rowspan="1" colspan="1">553.3 &#x000b1; 67.3</td><td align="left" valign="top" rowspan="1" colspan="1">470.9 &#x000b1; 85.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.026</td><td align="left" valign="top" rowspan="1" colspan="1">480.9 &#x000b1; 120.5</td><td align="left" valign="top" rowspan="1" colspan="1">486.1 &#x000b1; 98.6</td><td align="left" valign="top" rowspan="1" colspan="1">0.955</td><td align="left" valign="top" rowspan="1" colspan="1">0.140</td><td align="left" valign="top" rowspan="1" colspan="1">477.8 &#x000b1; 89.6</td><td align="left" valign="top" rowspan="1" colspan="1">0.019</td><td align="left" valign="top" rowspan="1" colspan="1">0.899</td><td align="left" valign="top" rowspan="1" colspan="1">0.067</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1-min STST, repetitions</td><td align="left" valign="top" rowspan="1" colspan="1">20.8 &#x000b1; 6.0</td><td align="left" valign="top" rowspan="1" colspan="1">17.9 &#x000b1; 6.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.136</td><td align="left" valign="top" rowspan="1" colspan="1">16.8 &#x000b1; 6.3</td><td align="left" valign="top" rowspan="1" colspan="1">16.6 &#x000b1;3.8</td><td align="left" valign="top" rowspan="1" colspan="1">1.000</td><td align="left" valign="top" rowspan="1" colspan="1">0.622</td><td align="left" valign="top" rowspan="1" colspan="1">17.4 &#x000b1; 5.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.045</td><td align="left" valign="top" rowspan="1" colspan="1">0.868</td><td align="left" valign="top" rowspan="1" colspan="1">0.212</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5-rep STST, s</td><td align="left" valign="top" rowspan="1" colspan="1">12.0 &#x000b1; 2.1</td><td align="left" valign="top" rowspan="1" colspan="1">12.3 &#x000b1; 2.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.981</td><td align="left" valign="top" rowspan="1" colspan="1">14.0 &#x000b1; 4.8</td><td align="left" valign="top" rowspan="1" colspan="1">14.7 &#x000b1; 3.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.380</td><td align="left" valign="top" rowspan="1" colspan="1">0.228</td><td align="left" valign="top" rowspan="1" colspan="1">13.2 &#x000b1; 3.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.421</td><td align="left" valign="top" rowspan="1" colspan="1">0.901</td><td align="left" valign="top" rowspan="1" colspan="1">0.527</td></tr></tbody></table><table-wrap-foot><fn><p>COPD: chronic obstructive pulmonary disease; FEV1% pred.: forced expiratory volume in one second % of target; 6-MWT: walking distance in 6-min walk test; m: meter; 1-min STST: 1-min sit-to-stand test; 5-rep STST: sit-to-stand test with five repetitions; WBVT: intervention group with whole-body vibration training; CTG: conventional training group.</p></fn></table-wrap-foot></table-wrap><p>Neither the STST, nor the 6-MWD showed significant differences in intra- or intergroup comparison for patients who completed the study. The quality of life, recorded via the CAT score, improved in the WBVT. Here, the minimal important difference of -2 points was achieved, though it was not reached for the CTG with -0.8 points (<xref ref-type="table" rid="T3">Table 3</xref>). However, the difference was not statistically significant. Quality of life measured by the CRQ showed a significant change for WBVT in the subgroups fatigue (P = 0.022), emotional function (P = 0.007), and mastery (P = 0.018). Furthermore, there was a significant difference between both groups for emotional function (P = 0.041). An overview of CRQ results is presented in <xref ref-type="table" rid="T4">Table 4</xref>.</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Comparison of Treatment Effects</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WBVT at baseline</th><th align="left" rowspan="1" colspan="1">WBVT at 3 months</th><th align="left" rowspan="1" colspan="1">Delta</th><th align="left" rowspan="1" colspan="1">Intragroup P-value</th><th align="left" rowspan="1" colspan="1">CTG at baseline</th><th align="left" rowspan="1" colspan="1">CTG at 3 months</th><th align="left" rowspan="1" colspan="1">Delta</th><th align="left" rowspan="1" colspan="1">Intragroup P-value</th><th align="left" rowspan="1" colspan="1">Intergroup P-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">FEV1% pred.</td><td align="left" valign="top" rowspan="1" colspan="1">48.4 &#x000b1; 20.9</td><td align="left" valign="top" rowspan="1" colspan="1">44.9 &#x000b1; 18.9</td><td align="left" valign="top" rowspan="1" colspan="1">-3.5&#x000b1; 22.5</td><td align="left" valign="top" rowspan="1" colspan="1">0.753</td><td align="left" valign="top" rowspan="1" colspan="1">51.2 &#x000b1; 17.3</td><td align="left" valign="top" rowspan="1" colspan="1">50.9 &#x000b1; 16.4</td><td align="left" valign="top" rowspan="1" colspan="1">-0.3 &#x000b1; 7.7</td><td align="left" valign="top" rowspan="1" colspan="1">0.683</td><td align="left" valign="top" rowspan="1" colspan="1">0.944</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6-MWD, m</td><td align="left" valign="top" rowspan="1" colspan="1">553 &#x000b1; 7</td><td align="left" valign="top" rowspan="1" colspan="1">561 &#x000b1; 9</td><td align="left" valign="top" rowspan="1" colspan="1">7&#x000b1; 55</td><td align="left" valign="top" rowspan="1" colspan="1">0.574</td><td align="left" valign="top" rowspan="1" colspan="1">481 &#x000b1; 121</td><td align="left" valign="top" rowspan="1" colspan="1">490 &#x000b1; 125</td><td align="left" valign="top" rowspan="1" colspan="1">9 &#x000b1; 45</td><td align="left" valign="top" rowspan="1" colspan="1">0.484</td><td align="left" valign="top" rowspan="1" colspan="1">0.798</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1-min STST, repetitions</td><td align="left" valign="top" rowspan="1" colspan="1">20.8 &#x000b1; 6.0</td><td align="left" valign="top" rowspan="1" colspan="1">20.9 &#x000b1; 8.4</td><td align="left" valign="top" rowspan="1" colspan="1">0.1 &#x000b1; 3.8</td><td align="left" valign="top" rowspan="1" colspan="1">0.937</td><td align="left" valign="top" rowspan="1" colspan="1">16.8 &#x000b1; 6.3</td><td align="left" valign="top" rowspan="1" colspan="1">18.1 &#x000b1; 7.5</td><td align="left" valign="top" rowspan="1" colspan="1">1.3 &#x000b1; 5.2</td><td align="left" valign="top" rowspan="1" colspan="1">0.420</td><td align="left" valign="top" rowspan="1" colspan="1">0.852</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5-rep STST, s</td><td align="left" valign="top" rowspan="1" colspan="1">11.9 &#x000b1; 2.1</td><td align="left" valign="top" rowspan="1" colspan="1">13.4 &#x000b1; 4.2</td><td align="left" valign="top" rowspan="1" colspan="1">1.4 &#x000b1; 3.3</td><td align="left" valign="top" rowspan="1" colspan="1">0.272</td><td align="left" valign="top" rowspan="1" colspan="1">13.9 &#x000b1; 4.8</td><td align="left" valign="top" rowspan="1" colspan="1">13.3 &#x000b1; 4.1</td><td align="left" valign="top" rowspan="1" colspan="1">-0.7 &#x000b1; 3.1</td><td align="left" valign="top" rowspan="1" colspan="1">0.326</td><td align="left" valign="top" rowspan="1" colspan="1">0.378</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CAT, pts.</td><td align="left" valign="top" rowspan="1" colspan="1">20.3 &#x000b1; 7.7</td><td align="left" valign="top" rowspan="1" colspan="1">17.8 &#x000b1; 7.2</td><td align="left" valign="top" rowspan="1" colspan="1">-2.4 &#x000b1; 2.7</td><td align="left" valign="top" rowspan="1" colspan="1">0.073</td><td align="left" valign="top" rowspan="1" colspan="1">20.8 &#x000b1; 5.5</td><td align="left" valign="top" rowspan="1" colspan="1">19.9 &#x000b1; 7.0</td><td align="left" valign="top" rowspan="1" colspan="1">-0.8 &#x000b1; 2.9</td><td align="left" valign="top" rowspan="1" colspan="1">0.321</td><td align="left" valign="top" rowspan="1" colspan="1">0.139</td></tr></tbody></table><table-wrap-foot><fn><p>FEV1% pred.: forced expiratory volume in one second % of target; 6-MWT: walking distance in 6-min walk test; m: meter; pts: points; 1-min STST: 1-min sit-to-stand test; 5-rep STST: sit-to-stand test with five repetitions; WBVT: intervention group with whole-body vibration training; CTG: conventional training group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Results CRQ</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">WBVT at baseline</th><th align="left" rowspan="1" colspan="1">WBVT at 3 months</th><th align="left" rowspan="1" colspan="1">Intragroup P-value</th><th align="left" rowspan="1" colspan="1">CTG at baseline</th><th align="left" rowspan="1" colspan="1">CTG at 3 months</th><th align="left" rowspan="1" colspan="1">Intragroup P-value</th><th align="left" rowspan="1" colspan="1">Intergroup P-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Dyspnea</td><td align="left" valign="top" rowspan="1" colspan="1">4.15 &#x000b1; 1.36</td><td align="left" valign="top" rowspan="1" colspan="1">4.58 &#x000b1; 1.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.222</td><td align="left" valign="top" rowspan="1" colspan="1">4.09 &#x000b1; 1.23</td><td align="left" valign="top" rowspan="1" colspan="1">4.20 &#x000b1; 1.15</td><td align="left" valign="top" rowspan="1" colspan="1">0.841</td><td align="left" valign="top" rowspan="1" colspan="1">0.560</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fatigue</td><td align="left" valign="top" rowspan="1" colspan="1">3.88 &#x000b1; 1.25</td><td align="left" valign="top" rowspan="1" colspan="1">4.48 &#x000b1; 1.32</td><td align="left" valign="top" rowspan="1" colspan="1">0.022</td><td align="left" valign="top" rowspan="1" colspan="1">3.86 &#x000b1; 0.89</td><td align="left" valign="top" rowspan="1" colspan="1">4.23 &#x000b1; 0.92</td><td align="left" valign="top" rowspan="1" colspan="1">0.058</td><td align="left" valign="top" rowspan="1" colspan="1">0.466</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Emotional function</td><td align="left" valign="top" rowspan="1" colspan="1">4.08 &#x000b1; 1.16</td><td align="left" valign="top" rowspan="1" colspan="1">4.92 &#x000b1; 1.19</td><td align="left" valign="top" rowspan="1" colspan="1">0.007</td><td align="left" valign="top" rowspan="1" colspan="1">4.27 &#x000b1; 1.10</td><td align="left" valign="top" rowspan="1" colspan="1">4.43 &#x000b1; 0.92</td><td align="left" valign="top" rowspan="1" colspan="1">0.421</td><td align="left" valign="top" rowspan="1" colspan="1">0.041</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mastery</td><td align="left" valign="top" rowspan="1" colspan="1">4.04 &#x000b1; 1.21</td><td align="left" valign="top" rowspan="1" colspan="1">5.04 &#x000b1; 1.40</td><td align="left" valign="top" rowspan="1" colspan="1">0.018</td><td align="left" valign="top" rowspan="1" colspan="1">4.34 &#x000b1; 1.30</td><td align="left" valign="top" rowspan="1" colspan="1">4.64 &#x000b1; 1.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.126</td><td align="left" valign="top" rowspan="1" colspan="1">0.052</td></tr></tbody></table><table-wrap-foot><fn><p>CRQ: Chronic respiratory disease questionnaire; WBVT: intervention group with whole-body vibration training; CTG: conventional training group.</p></fn></table-wrap-foot></table-wrap><p>Adverse events, as defined in the protocol, were not observed.</p></sec><sec id="s4"><title>Discussion</title><p>In the present study, no significant effects on exercise capacity could be found with the training protocol used in this study. The primary outcome parameter (STST) did not change significantly in any group. With an improvement of 7 m (WBVT) and 9 m (CTG), neither group exceeded the MID of 30 m for the 6-MWT. These results are not consistent with previous findings. We assume multiple reasons for this. Firstly, participants with the greatest physical impairments, and thus the largest potential for improvement, dropped out of the study especially in the WBVT group due to several reasons. Literature suggests that typically participants with reduced exercise capacity benefit most from physical training [<xref rid="R23" ref-type="bibr">23</xref>]. Gloeckl et al demonstrated a statistically significant improvement following a WBVT intervention (+27 m) using WBVT as a complementary exercise modality on top of conventional endurance and strength training [<xref rid="R14" ref-type="bibr">14</xref>].</p><p>In most training studies, the benefits of training interventions are demonstrated during outpatient rehabilitation programs with poorly trained participants. In our study, 71% of participants (n = 39) starting the study took already part in a regular training program. This might explain the relatively high baseline values for exercise capacity (as measured by STST and 6-MWT).</p><p>We furthermore assume that a training session only once a week might have been too less, thus neither of the groups showed significant changes. The current training guidelines from the American College of Sports Medicine recommend a training frequency of 3 - 5 times per week [<xref rid="R24" ref-type="bibr">24</xref>]. However, these recommendations are difficult to realize for COPD patients in the long-term. Therefore, there seems to be a trade-off between lower frequency and thus feasible training and the training effect for COPD patients. Despite the rather low training frequency, a high discontinuation rate of 49% for both groups was observed in our study. Typically, discontinuation rates in training studies are found to be between 20% and 40% [<xref rid="R25" ref-type="bibr">25</xref>]. Furthermore, the dropout rate in our study was very high compared with dropout rates reported in studies using WBVT in other patient populations [<xref rid="R26" ref-type="bibr">26-28</xref>]. However, the dropout rate in both groups was similar and all dropout reasons were not directly related to the intervention (for reasons, <xref ref-type="fig" rid="F1">Fig. 1</xref>). Unfortunately patients who dropped out of the WBVT group were patients with significantly lower exercise capacity compared to completers (<xref ref-type="table" rid="T2">Table 2</xref>). This might have led to a certain underestimation of WBVT effects, because patients with lower exercise capacity have been shown to have the most potential for improvement [<xref rid="R23" ref-type="bibr">23</xref>]. Nevertheless, our results may be interpreted with caution due to the high dropout rate of 49%.</p><p>Another cause for the quite low benefit of our 12-week training intervention is the homogeneity in the training content. Both groups performed the same training, with the exception of using WBVT during squat training. Surely, one cannot expect a large additional training effect by varying only a single and small modality in the context of an entire training concept. This result is in accordance with the conclusions drawn by Salhi et al [<xref rid="R25" ref-type="bibr">25</xref>]. Another approach for explaining the lack of improvement is the difficulties associated with standardizing training content, as well as intensity during regular PR. It was not documented, how intensively the participants exercised during the remaining training program (heart rate, SpO<sub>2</sub>, Borg, etc.)</p><p>We nevertheless observed an improvement in the CAT score and partially in the area of health-related quality of life, despite the lack of an increase in exercise capacity in the WBVT group. Some differences in the CRQ domains were statistically significant but not of clinical relevance. However, due to the low number of participants completing the study, we should not over-interpret these results.</p><p>There are also some limitations in our study that need to be considered. We have registered a very high dropout rate of 49%, leading to a sample size below the a priori calculated power calculation. Therefore, this major limitation of our study should be taken into account when interpreting our results. The rather high level in baseline exercise capacity for completers limited a higher improvement in exercise capacity by a low frequency training program. In contrast, Salhi et al solely included patients with a 6-MWT of &#x0003c; 70% pred. in their study. Potentially our participants also could have benefitted from training with additional weight to induce a sufficient training stimulus [<xref rid="R25" ref-type="bibr">25</xref>]. In their systematic review, Gloeckl et al described that especially patients with muscular impairments benefit from WBVT by training solely with their own body weight [<xref rid="R15" ref-type="bibr">15</xref>]. Our protocol also did not consider an increase in vibration frequency, which might have further limited the effect of WBVT. Similar to our study the results of the study by Furness et al showed that WBVT did not exacerbate symptoms of COPD [<xref rid="R29" ref-type="bibr">29</xref>]. Additionally, our study has shown that patients are at least able to maintain their exercise performance in the context of the 3 months exercise training which can be seen as an important benefit in patients with COPD. However, in another recent study with a small sample size WBVT improved functional capacity in the 6-MWT of patients with COPD undergoing a training program on the vibrating platform as well as in all domains of the SGRQ quality of life in a safe and feasible way [<xref rid="R30" ref-type="bibr">30</xref>].</p><sec id="s4a"><title>Conclusion</title><p>WBVT was feasible and safe in patients with COPD during an outpatient low frequency exercise program. However, a benefit on exercise capacity could not be demonstrated with the use of an additional WBVT. It is assumed that the reason for this lack of improvement relies in the low volume and intensity of training sessions, calling for studies with higher training frequencies. Additionally, a high dropout rate is further weakening the reliability of this study.</p></sec></sec></body><back><sec id="s5"><title>Conflicts of Interest</title><p>The authors have reported that no potential conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.</p></sec><sec id="s6"><title>Author Contributions</title><p>MS and RG contributed to the study hypothesis, study design, writing the manuscript and sharing scientific discussions. JMG contributed to the organization of the study, data collection and sharing scientific discussions. CN contributed to the statistical analysis of the study and data collection. ARK, TB and JHS reviewed the manuscript, and shared scientific discussions. WW contributed to the study design, reviewed the manuscript and shared scientific discussions. All authors have read and approved the manuscript.</p></sec><ref-list><title>References</title><ref id="R01"><label>1</label><element-citation publication-type="journal"><name><surname>Goldstein</surname><given-names>J</given-names></name><name><surname>Plioplys</surname><given-names>S</given-names></name><name><surname>Zelko</surname><given-names>F</given-names></name><name><surname>Mass</surname><given-names>S</given-names></name><name><surname>Corns</surname><given-names>C</given-names></name><name><surname>Blaufuss</surname><given-names>R</given-names></name><name><surname>Nordli</surname><given-names>D</given-names></name><article-title>Multidisciplinary approach to childhood epilepsy: exploring the scientific rationale and practical aspects of implementation</article-title><source>J Child Neurol</source><year>2004</year><volume>19</volume><issue>5</issue><fpage>362</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1177/088307380401900509</pub-id><pub-id pub-id-type="pmid">15224709</pub-id></element-citation></ref><ref id="R02"><label>2</label><element-citation publication-type="journal"><name><surname>Griffiths</surname><given-names>TL</given-names></name><name><surname>Burr</surname><given-names>ML</given-names></name><name><surname>Campbell</surname><given-names>IA</given-names></name><name><surname>Lewis-Jenkins</surname><given-names>V</given-names></name><name><surname>Mullins</surname><given-names>J</given-names></name><name><surname>Shiels</surname><given-names>K</given-names></name><name><surname>Turner-Lawlor</surname><given-names>PJ</given-names></name><etal>et al</etal><article-title>Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial</article-title><source>Lancet</source><year>2000</year><volume>355</volume><issue>9201</issue><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(99)07042-7</pub-id><pub-id pub-id-type="pmid">10665556</pub-id></element-citation></ref><ref id="R03"><label>3</label><element-citation publication-type="journal"><name><surname>Puhan</surname><given-names>MA</given-names></name><name><surname>Gimeno-Santos</surname><given-names>E</given-names></name><name><surname>Scharplatz</surname><given-names>M</given-names></name><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Walters</surname><given-names>EH</given-names></name><name><surname>Steurer</surname><given-names>J</given-names></name><article-title>Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease</article-title><source>Cochrane Database Syst Rev</source><year>2011</year><volume>10</volume><fpage>CD005305</fpage><pub-id pub-id-type="doi">10.1002/14651858.cd005305.pub3</pub-id></element-citation></ref><ref id="R04"><label>4</label><element-citation publication-type="journal"><name><surname>Kon</surname><given-names>SS</given-names></name><name><surname>Canavan</surname><given-names>JL</given-names></name><name><surname>Man</surname><given-names>WD</given-names></name><article-title>Pulmonary rehabilitation and acute exacerbations of COPD</article-title><source>Expert Rev Respir Med</source><year>2012</year><volume>6</volume><issue>5</issue><fpage>523</fpage><lpage>531</lpage><comment>quiz 531</comment><pub-id pub-id-type="doi">10.1586/ers.12.47</pub-id><pub-id pub-id-type="pmid">23134247</pub-id></element-citation></ref><ref id="R05"><label>5</label><element-citation publication-type="journal"><name><surname>Ries</surname><given-names>AL</given-names></name><name><surname>Bauldoff</surname><given-names>GS</given-names></name><name><surname>Carlin</surname><given-names>BW</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Emery</surname><given-names>CF</given-names></name><name><surname>Mahler</surname><given-names>DA</given-names></name><name><surname>Make</surname><given-names>B</given-names></name><etal>et al</etal><article-title>Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines</article-title><source>Chest</source><year>2007</year><volume>131</volume><issue>5 Suppl</issue><fpage>4S</fpage><lpage>42S</lpage><pub-id pub-id-type="doi">10.1378/chest.06-2418</pub-id><pub-id pub-id-type="pmid">17494825</pub-id></element-citation></ref><ref id="R06"><label>6</label><element-citation publication-type="journal"><name><surname>Spruit</surname><given-names>MA</given-names></name><name><surname>Singh</surname><given-names>SJ</given-names></name><name><surname>Garvey</surname><given-names>C</given-names></name><etal>et al</etal><article-title>ATS/ERS Task Force on Pulmonary Rehabilitation, an official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation</article-title><source>Am J RespirCrit Care Med</source><year>2014</year><volume>189</volume><issue>12</issue><fpage>1570</fpage></element-citation></ref><ref id="R07"><label>7</label><element-citation publication-type="journal"><name><surname>Troosters</surname><given-names>T</given-names></name><name><surname>Gosselink</surname><given-names>R</given-names></name><name><surname>Janssens</surname><given-names>W</given-names></name><name><surname>Decramer</surname><given-names>M</given-names></name><article-title>Exercise training and pulmonary rehabilitation: new insights and remaining challenges</article-title><source>Eur Respir Rev</source><year>2010</year><volume>19</volume><issue>115</issue><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1183/09059180.00007809</pub-id><pub-id pub-id-type="pmid">20956162</pub-id></element-citation></ref><ref id="R08"><label>8</label><element-citation publication-type="journal"><article-title>Bundesarbeitsgemeinschaft fur Rehabilitation: Rahmenempfehlungen fur den Rehabilitationssport und das Funktionstraining vom 1</article-title><source>Oktober 2003 in der Form vom Januar 2011 Verfugbar unter: www.bar-frankfurt.de</source></element-citation></ref><ref id="R09"><label>9</label><element-citation publication-type="journal"><article-title>Bundesarbeitsgemeinschaft fur Rehabilitation (BAR) e.V.</article-title><source>Rahmenvereinbarung uber den Rehabilitationssport und das Funktionstraining 2011; ISBN 978-3-9813712-5-3</source></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><name><surname>Gohl</surname><given-names>OC</given-names></name><article-title>Training bei COPD</article-title><source>Berchtesgaden 2012. ISBN 978-3-00-040743-7</source></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><name><surname>Spielmanns</surname><given-names>M</given-names></name><name><surname>Gohl</surname><given-names>O</given-names></name><name><surname>Schultz</surname><given-names>K</given-names></name><name><surname>Worth</surname><given-names>H</given-names></name><article-title>[Lung exercise: outpatient exercise program has long-term benefits on COPD]</article-title><source>Dtsch Med Wochenschr</source><year>2015</year><volume>140</volume><issue>13</issue><fpage>1001</fpage><lpage>1005</lpage><pub-id pub-id-type="doi">10.1055/s-0041-102720</pub-id><pub-id pub-id-type="pmid">26115136</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><name><surname>Merkert</surname><given-names>J</given-names></name><name><surname>Butz</surname><given-names>S</given-names></name><name><surname>Nieczaj</surname><given-names>R</given-names></name><name><surname>Steinhagen-Thiessen</surname><given-names>E</given-names></name><name><surname>Eckardt</surname><given-names>R</given-names></name><article-title>Combined whole body vibration and balance training using Vibrosphere(R): improvement of trunk stability, muscle tone, and postural control in stroke patients during early geriatric rehabilitation</article-title><source>Z Gerontol Geriatr</source><year>2011</year><volume>44</volume><issue>4</issue><fpage>256</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1007/s00391-011-0170-9</pub-id><pub-id pub-id-type="pmid">21505939</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><name><surname>Zha</surname><given-names>DS</given-names></name><name><surname>Zhu</surname><given-names>QA</given-names></name><name><surname>Pei</surname><given-names>WW</given-names></name><name><surname>Zheng</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>SH</given-names></name><name><surname>Xu</surname><given-names>ZX</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><etal>et al</etal><article-title>Does whole-body vibration with alternative tilting increase bone mineral density and change bone metabolism in senior people?</article-title><source>Aging Clin Exp Res</source><year>2012</year><volume>24</volume><issue>1</issue><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">21339698</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><name><surname>Gloeckl</surname><given-names>R</given-names></name><name><surname>Heinzelmann</surname><given-names>I</given-names></name><name><surname>Baeuerle</surname><given-names>S</given-names></name><name><surname>Damm</surname><given-names>E</given-names></name><name><surname>Schwedhelm</surname><given-names>AL</given-names></name><name><surname>Diril</surname><given-names>M</given-names></name><name><surname>Buhrow</surname><given-names>D</given-names></name><etal>et al</etal><article-title>Effects of whole body vibration in patients with chronic obstructive pulmonary disease - a randomized controlled trial</article-title><source>Respir Med</source><year>2012</year><volume>106</volume><issue>1</issue><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2011.10.021</pub-id><pub-id pub-id-type="pmid">22104540</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><name><surname>Gloeckl</surname><given-names>R</given-names></name><name><surname>Heinzelmann</surname><given-names>I</given-names></name><name><surname>Kenn</surname><given-names>K</given-names></name><article-title>Whole body vibration training in patients with COPD: A systematic review</article-title><source>Chron Respir Dis</source><year>2015</year><volume>12</volume><issue>3</issue><fpage>212</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1177/1479972315583049</pub-id><pub-id pub-id-type="pmid">25904085</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><name><surname>Wanger</surname><given-names>J</given-names></name><name><surname>Clausen</surname><given-names>JL</given-names></name><name><surname>Coates</surname><given-names>A</given-names></name><name><surname>Pedersen</surname><given-names>OF</given-names></name><name><surname>Brusasco</surname><given-names>V</given-names></name><name><surname>Burgos</surname><given-names>F</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><etal>et al</etal><article-title>Standardisation of the measurement of lung volumes</article-title><source>Eur Respir J</source><year>2005</year><volume>26</volume><issue>3</issue><fpage>511</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1183/09031936.05.00035005</pub-id><pub-id pub-id-type="pmid">16135736</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><name><surname>Miller</surname><given-names>MR</given-names></name><name><surname>Hankinson</surname><given-names>J</given-names></name><name><surname>Brusasco</surname><given-names>V</given-names></name><name><surname>Burgos</surname><given-names>F</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Coates</surname><given-names>A</given-names></name><name><surname>Crapo</surname><given-names>R</given-names></name><etal>et al</etal><article-title>Standardisation of spirometry</article-title><source>Eur Respir J</source><year>2005</year><volume>26</volume><issue>2</issue><fpage>319</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1183/09031936.05.00034805</pub-id><pub-id pub-id-type="pmid">16055882</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><name><surname>Quanjer</surname><given-names>PH</given-names></name><name><surname>Tammeling</surname><given-names>GJ</given-names></name><name><surname>Cotes</surname><given-names>JE</given-names></name><name><surname>Pedersen</surname><given-names>OF</given-names></name><name><surname>Peslin</surname><given-names>R</given-names></name><name><surname>Yernault</surname><given-names>JC</given-names></name><article-title>Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society</article-title><source>Eur Respir J Suppl</source><year>1993</year><volume>16</volume><fpage>5</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1183/09041950.005s1693</pub-id><pub-id pub-id-type="pmid">8499054</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><name><surname>Ozalevli</surname><given-names>S</given-names></name><name><surname>Ozden</surname><given-names>A</given-names></name><name><surname>Itil</surname><given-names>O</given-names></name><name><surname>Akkoclu</surname><given-names>A</given-names></name><article-title>Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease</article-title><source>Respir Med</source><year>2007</year><volume>101</volume><issue>2</issue><fpage>286</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2006.05.007</pub-id><pub-id pub-id-type="pmid">16806873</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><article-title>ATS statement: guidelines for the six-minute walk test</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><issue>1</issue><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.166.1.at1102</pub-id><pub-id pub-id-type="pmid">12091180</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><name><surname>Puhan</surname><given-names>MA</given-names></name><name><surname>Behnke</surname><given-names>M</given-names></name><name><surname>Frey</surname><given-names>M</given-names></name><name><surname>Grueter</surname><given-names>T</given-names></name><name><surname>Brandli</surname><given-names>O</given-names></name><name><surname>Lichtenschopf</surname><given-names>A</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><etal>et al</etal><article-title>Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies</article-title><source>Health Qual Life Outcomes</source><year>2004</year><volume>2</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1477-7525-2-1</pub-id><pub-id pub-id-type="pmid">14713317</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><name><surname>Jones</surname><given-names>PW</given-names></name><name><surname>Harding</surname><given-names>G</given-names></name><name><surname>Berry</surname><given-names>P</given-names></name><name><surname>Wiklund</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>WH</given-names></name><name><surname>Kline Leidy</surname><given-names>N</given-names></name><article-title>Development and first validation of the COPD Assessment Test</article-title><source>Eur Respir J</source><year>2009</year><volume>34</volume><issue>3</issue><fpage>648</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1183/09031936.00102509</pub-id><pub-id pub-id-type="pmid">19720809</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><name><surname>Kenn</surname><given-names>K</given-names></name><name><surname>Gloeckl</surname><given-names>R</given-names></name><name><surname>Soennichsen</surname><given-names>A</given-names></name><name><surname>Sczepanski</surname><given-names>B</given-names></name><name><surname>Winterkamp</surname><given-names>S</given-names></name><name><surname>Boensch</surname><given-names>M</given-names></name><name><surname>Welte</surname><given-names>T</given-names></name><article-title>Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation</article-title><source>Transplantation</source><year>2015</year><volume>99</volume><issue>5</issue><fpage>1072</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1097/TP.0000000000000472</pub-id><pub-id pub-id-type="pmid">25393161</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="book" publication-format="print"><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Arena</surname><given-names>R</given-names></name><name><surname>Riebe</surname><given-names>D</given-names></name><etal>et al</etal><chapter-title>Exercise Prescription for other clinical populations: Chronic obtsructive pulmonary disease. Chapter 10</chapter-title><source>ACSM`s Guidelines for Exercise testing and Prescription</source><edition>9th Edition</edition><publisher-loc>Lippincott</publisher-loc><publisher-name>Williams&#x00026;Wilkins</publisher-name><year>2014</year><fpage>334</fpage><lpage>337</lpage></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><name><surname>Salhi</surname><given-names>B</given-names></name><name><surname>Malfait</surname><given-names>TJ</given-names></name><name><surname>Van Maele</surname><given-names>G</given-names></name><name><surname>Joos</surname><given-names>G</given-names></name><name><surname>van Meerbeeck</surname><given-names>JP</given-names></name><name><surname>Derom</surname><given-names>E</given-names></name><article-title>Effects of Whole Body Vibration in Patients With COPD</article-title><source>COPD</source><year>2015</year><volume>12</volume><issue>5</issue><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.3109/15412555.2015.1008693</pub-id><pub-id pub-id-type="pmid">26457458</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><name><surname>Madou</surname><given-names>KH</given-names></name><name><surname>Cronin</surname><given-names>JB</given-names></name><article-title>The Effect of Whole body vibration on physical and physiological capability in special populations</article-title><source>Hong Kong Physiotherapy</source><year>2008</year><volume>26</volume><fpage>24</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/S1013-7025(09)70005-3</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Wust</surname><given-names>M</given-names></name><name><surname>Rawer</surname><given-names>R</given-names></name><name><surname>Schnabel</surname><given-names>D</given-names></name><name><surname>Armbrecht</surname><given-names>G</given-names></name><name><surname>Beller</surname><given-names>G</given-names></name><name><surname>Rembitzki</surname><given-names>I</given-names></name><etal>et al</etal><article-title>Whole body vibration in cystic fibrosis - a pilot study</article-title><source>J Musculoskelet Neuronal Interact</source><year>2008</year><volume>8</volume><issue>2</issue><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">18622087</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><name><surname>Rietschel</surname><given-names>E</given-names></name><name><surname>van Koningsbruggen</surname><given-names>S</given-names></name><name><surname>Fricke</surname><given-names>O</given-names></name><name><surname>Semler</surname><given-names>O</given-names></name><name><surname>Schoenau</surname><given-names>E</given-names></name><article-title>Whole body vibration: a new therapeutic approach to improve muscle function in cystic fibrosis?</article-title><source>Int J Rehabil Res</source><year>2008</year><volume>31</volume><issue>3</issue><fpage>253</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1097/MRR.0b013e3282fb783d</pub-id><pub-id pub-id-type="pmid">18708849</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><name><surname>Furness</surname><given-names>T</given-names></name><name><surname>Joseph</surname><given-names>C</given-names></name><name><surname>Naughton</surname><given-names>G</given-names></name><name><surname>Welsh</surname><given-names>L</given-names></name><name><surname>Lorenzen</surname><given-names>C</given-names></name><article-title>Benefits of whole-body vibration to people with COPD: a community-based efficacy trial</article-title><source>BMC Pulm Med</source><year>2014</year><volume>14</volume><fpage>38</fpage><pub-id pub-id-type="doi">10.1186/1471-2466-14-38</pub-id><pub-id pub-id-type="pmid">24606997</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><name><surname>Braz Junior</surname><given-names>DS</given-names></name><name><surname>Dornelas de Andrade</surname><given-names>A</given-names></name><name><surname>Teixeira</surname><given-names>AS</given-names></name><name><surname>Cavalcanti</surname><given-names>CA</given-names></name><name><surname>Morais</surname><given-names>AB</given-names></name><name><surname>Marinho</surname><given-names>PE</given-names></name><article-title>Whole-body vibration improves functional capacity and quality of life in patients with severe chronic obstructive pulmonary disease (COPD): a pilot study</article-title><source>Int J Chron Obstruct Pulmon Dis</source><year>2015</year><volume>10</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">25624756</pub-id></element-citation></ref></ref-list></back></article>